Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1006

1.

Physician and practice characteristics associated with the early utilization of new prescription drugs.

Tamblyn R, McLeod P, Hanley JA, Girard N, Hurley J.

Med Care. 2003 Aug;41(8):895-908. Erratum in: Med Care. 2003 Oct;41(10):1117.

PMID:
12886170
2.

Physician characteristics and prescribing for elderly people in New Brunswick: relation to patient outcomes.

Davidson W, Molloy DW, Bédard M.

CMAJ. 1995 Apr 15;152(8):1227-34. Erratum in: Can Med Assoc J 1995 Jul 15;153(2):142.

3.

Is new drug prescribing in primary care specialist induced?

Florentinus SR, Heerdink ER, van Dijk L, Griens AM, Groenewegen PP, Leufkens HG.

BMC Health Serv Res. 2009 Jan 11;9:6. doi: 10.1186/1472-6963-9-6.

4.

Hormone therapy prescription among physicians in France and Quebec.

Ringa V, Légaré F, Dodin S, Norton J, Godin G, Bréart G.

Menopause. 2004 Jan-Feb;11(1):89-97.

PMID:
14716188
5.

Relation between physician characteristics and prescribing for elderly people in New Brunswick.

Davidson W, Molloy DW, Somers G, Bédard M.

CMAJ. 1994 Mar 15;150(6):917-21.

6.

Method of physician remuneration and rates of antibiotic prescription.

Hutchinson JM, Foley RN.

CMAJ. 1999 Apr 6;160(7):1013-7.

7.

Diffusion of new drugs in Danish general practice.

Steffensen FH, Sørensen HT, Olesen F.

Fam Pract. 1999 Aug;16(4):407-13.

8.

The impact of specialists on prescribing by general practitioners.

Robertson J, Fryer JL, O'Connell DL, Sprogis A, Henry DA.

Med J Aust. 2001 Oct 15;175(8):407-11.

PMID:
11700832
9.

Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.

Anderson DR, Gardner MJ, Putnam W, Jassal D, Brownell B, Flowerdew G, Nagpal S, Thompson K, Cox JL.

Can J Cardiol. 2005 Mar;21(3):257-66.

PMID:
15776115
10.

Characterizing early prescribers of newly marketed drugs in Canada: a population-based study.

Kozyrskyj A, Raymond C, Racher A.

Eur J Clin Pharmacol. 2007 Jun;63(6):597-604. Epub 2007 Mar 23.

PMID:
17380324
11.

Characteristics and quality of prescribing by doctors practicing in nursing homes.

Beers MH, Fingold SF, Ouslander JG, Reuben DB, Morgenstern H, Beck JC.

J Am Geriatr Soc. 1993 Aug;41(8):802-7.

PMID:
8340556
12.

Physician characteristics in relation to cardiovascular drugs commonly prescribed for hypertension in Nova Scotia.

Burge F, Kephart G, Flowerdew G, Putnam W, Comeau DG, Whelan AM, Sketris I, Sclar D.

Can J Clin Pharmacol. 2001 Fall;8(3):139-45.

PMID:
11574896
13.

Adoption of new drugs by physicians: a survival analysis.

Garjón FJ, Azparren A, Vergara I, Azaola B, Loayssa JR.

BMC Health Serv Res. 2012 Mar 8;12:56. doi: 10.1186/1472-6963-12-56.

14.

Early discontinuation: more frequent among general practitioners with high levels of prescribing.

Hansen DG, Gichangi A, Vach W, Felde LH, Larsen J.

Eur J Clin Pharmacol. 2007 Sep;63(9):861-5. Epub 2007 Jul 6.

PMID:
17618428
15.

Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of Italy.

Orzella L, Chini F, Giorgi Rossi P, Borgia P.

Health Policy. 2010 May;95(2-3):236-44. doi: 10.1016/j.healthpol.2009.12.005. Epub 2010 Jan 4.

PMID:
20047773
16.

Prescribing trends by nurse practitioners and physician assistants in the United States.

Cipher DJ, Hooker RS, Guerra P.

J Am Acad Nurse Pract. 2006 Jun;18(6):291-6.

PMID:
16719848
17.

Does the early adopter of drugs exist? A population-based study of general practitioners' prescribing of new drugs.

Dybdahl T, Andersen M, Søndergaard J, Kragstrup J, Kristiansen IS.

Eur J Clin Pharmacol. 2004 Nov;60(9):667-72. Epub 2004 Oct 21. Erratum in: Eur J Clin Pharmacol. 2005 Mar;61(1):75.

PMID:
15502995
18.

Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics.

Hansen DG, Vach W, Rosholm JU, Søndergaard J, Gram LF, Kragstrup J.

Fam Pract. 2004 Dec;21(6):623-9. Epub 2004 Nov 1.

19.
Items per page

Supplemental Content

Write to the Help Desk